MCKESSON CORP
MCKNYSETrading Snapshot
- Day Range
- $896.26 β $915.28
- 52-Week Range
- $637.00 β $999.00
- Volume
- $3.73B
- Avg Volume
- $3.32B
- Shares Outstanding
- 117.1M
- Next Earnings
- Sep 6, 2026
Fundamentals Snapshot
- Annual Revenue
- $407.40B
- Last Q Revenue
- $92.64B
- P/E Ratio
- 22.5
- P/S Ratio
- 0.3x
- EPS (TTM)
- $37.35
- Dividend Yield
- 0.38%
Why Investors Own MCK
- βHigh-growth profile β revenue up -8.5% YoY with expanding US Equity exposure.
- βHealthy economics β 56% gross margin and 24% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
About MCKESSON CORP
A company profile for MCKESSON CORP isnβt available yet β check back soon.
Otter Score Breakdown
βAnalyst Ratings
βLatest News & Updates
Wells Fargo Maintains Equal-Weight on McKesson, Raises Price Target to $933
Wells Fargo analyst Stephen Baxter maintains McKesson (NYSE:MCK) with a Equal-Weight and raises the price target from $812 to $933.
QDEL Q2 Earnings & Revenues Beat Estimates, 2026 Guidance Lowered
QuidelOrtho beats Q2 earnings and revenue estimates, but cuts its 2026 outlook on persistent China weakness and a softer respiratory testing environment.
Integer Holdings Q2 Earnings & Revenues Top Estimates, Margins Decline
ITGR beats Q2 earnings and revenue estimates, but sales and margins decrease as product headwinds persist ahead of its $5.7B KKR deal.
McKesson Q1 Earnings Call Highlights
McKesson (NYSE:MCK) reported fiscal first-quarter 2027 results that exceeded its expectations, citing broad-based momentum across its operating businesses and prompting the healthcare services company to raise its full-year adjusted earnings outlook. Revenue rose 8% to $105.4 billion, while adjuste
Dividend Announcements: July 18-24, 2026
Weekly dividend stock update: 24 hikes, 1 cut. Read to see top raises like FIX & MCK, HONΓ’ΒΒs spinoff impact, and how to spot safe income.
How Higher Sales, Lower EPS And New Guidance At McKesson (MCK) Has Changed Its Investment Story
On August 5, 2026, McKesson Corporation reported first-quarter fiscal 2027 results showing sales of US$105.38 billion, higher than a year earlier, while net income and earnings per share from continuing operations declined year-on-year. Alongside these results, McKesson completed a large portion of its long-running share repurchase program and raised adjusted earnings guidance, highlighting managementβs confidence in specialty and oncology growth, technology and AI investments, and the...